Effect of Internet-Delivered Emotion Regulation Individual Therapy for Adolescents With Nonsuicidal Self-Injury Disorder: A Randomized Clinical Trial.


Journal

JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235

Informations de publication

Date de publication:
03 Jul 2023
Historique:
medline: 17 7 2023
pubmed: 13 7 2023
entrez: 13 7 2023
Statut: epublish

Résumé

Nonsuicidal self-injury is prevalent in adolescence and associated with adverse clinical outcomes. Effective interventions that are brief, transportable, and scalable are lacking. To test the hypotheses that an internet-delivered emotion regulation individual therapy for adolescents delivered adjunctive to treatment as usual is superior to treatment as usual only in reducing nonsuicidal self-injury and that improvements in emotion regulation mediate these treatment effects. This 3-site, single-masked, randomized superiority trial enrolled participants from November 20, 2017, to April 9, 2020. Eligible participants were aged between 13 and 17 years and met diagnostic criteria for nonsuicidal self-injury disorder; they were enrolled as a mixed cohort of consecutive patients and volunteers. Parents participated in parallel to their children. The primary end point was at 1 month after treatment. Participants were followed up at 3 months posttreatment. Data collection ended in January 2021. Twelve weeks of therapist-guided, internet-delivered emotion regulation individual therapy delivered adjunctive to treatment as usual vs treatment as usual only. Primary outcome was the youth version of the Deliberate Self-harm Inventory, both self-reported by participants prior to treatment, once every week during treatment, and for 4 weeks posttreatment, and clinician-rated by masked assessors prior to treatment and at 1 and 3 months posttreatment. A total of 166 adolescents (mean [SD] age, 15.0 [1.2] years; 154 [92.8%] female) were randomized to internet-delivered emotion regulation therapy plus treatment as usual (84 participants) or treatment as usual only (82 participants). The experimental intervention was superior to the control condition in reducing clinician-rated nonsuicidal self-injury (82% vs 47% reduction; incidence rate ratio, 0.34; 95% CI, 0.20-0.57) from pretreatment to 1-month posttreatment. These results were maintained at 3-month posttreatment. Improvements in emotion dysregulation mediated improvements in self-injury during treatment. In this randomized clinical trial, a 12-week, therapist-guided, internet-delivered emotion regulation therapy delivered adjunctive to treatment as usual was efficacious in reducing self-injury, and mediation analysis supported the theorized role of emotion regulation as the mechanism of change in this treatment. This treatment may increase availability of evidence-based psychological treatments for adolescents with nonsuicidal self-injury. ClinicalTrials.gov Identifier: NCT03353961.

Identifiants

pubmed: 37440232
pii: 2807193
doi: 10.1001/jamanetworkopen.2023.22069
pmc: PMC10346121
doi:

Banques de données

ClinicalTrials.gov
['NCT03353961']

Types de publication

Randomized Controlled Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2322069

Références

J Clin Child Adolesc Psychol. 2019 May-Jun;48(3):357-392
pubmed: 31046461
Psychother Psychosom Med Psychol. 2001 May;51(5):201-11
pubmed: 11417358
Child Adolesc Psychiatry Ment Health. 2015 Sep 28;9:31
pubmed: 26417387
Cochrane Database Syst Rev. 2021 Mar 7;3:CD013667
pubmed: 33677832
J Psychopathol Behav Assess. 2016 Jun;38(2):284-296
pubmed: 27239096
Suicide Life Threat Behav. 2020 Feb;50(1):151-179
pubmed: 31448847
Psychol Bull. 2020 Dec;146(12):1117-1145
pubmed: 33119344
Psychol Med. 2016 Jan;46(2):225-36
pubmed: 26370729
Lancet Psychiatry. 2018 Mar;5(3):237-286
pubmed: 29482764
J Am Acad Child Adolesc Psychiatry. 2014 Oct;53(10):1082-91
pubmed: 25245352
Struct Equ Modeling. 2003 Apr 1;10(2):238
pubmed: 20157639
Psychol Med. 2014 Jul;44(10):2099-112
pubmed: 23985088
Psychol Methods. 2010 Dec;15(4):309-34
pubmed: 20954780
Behav Res Ther. 1995 Mar;33(3):335-43
pubmed: 7726811
JAMA Psychiatry. 2020 Dec 1;77(12):1205-1206
pubmed: 32391857
JAMA Psychiatry. 2018 Aug 1;75(8):777-785
pubmed: 29926087
Personal Disord. 2012 Jan;3(1):39-54
pubmed: 22448860
JMIR Form Res. 2021 Jul 23;5(7):e17910
pubmed: 34297001
BMC Psychiatry. 2018 Oct 11;18(1):326
pubmed: 30305103
J Child Psychol Psychiatry. 2019 Mar;60(3):295-304
pubmed: 30207392
J Child Psychol Psychiatry. 2022 Aug;63(8):921-928
pubmed: 34856636
BMC Psychiatry. 2017 Dec 28;17(1):411
pubmed: 29282024
Arch Gen Psychiatry. 1983 Nov;40(11):1228-31
pubmed: 6639293
J Child Psychol Psychiatry. 2019 Oct;60(10):1043-1045
pubmed: 31512762
BMJ. 2014 Oct 21;349:g5954
pubmed: 25335825

Auteurs

Johan Bjureberg (J)

Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet, & Stockholm Health Care Services, Region Stockholm, Stockholm, Sweden.

Olivia Ojala (O)

Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet, & Stockholm Health Care Services, Region Stockholm, Stockholm, Sweden.

Hugo Hesser (H)

School of Law, Psychology and Social Work, Örebro University, Örebro, Sweden.

Henrike Häbel (H)

Division of Biostatistics, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.

Hanna Sahlin (H)

Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet, & Stockholm Health Care Services, Region Stockholm, Stockholm, Sweden.

Kim L Gratz (KL)

Department of Psychology, University of Toledo, Toledo, Ohio.
Lyra Health, Burlingame, California.

Matthew T Tull (MT)

Department of Psychology, University of Toledo, Toledo, Ohio.

Emma Claesdotter Knutsson (E)

Department of Clinical Sciences Lund, Faculty of Medicine, Lund University, Lund, Sweden.

Erik Hedman-Lagerlöf (E)

Department of Clinical Neuroscience, Division of Psychology, Karolinska Institutet, Stockholm, Sweden.

Brjánn Ljótsson (B)

Department of Clinical Neuroscience, Division of Psychology, Karolinska Institutet, Stockholm, Sweden.

Clara Hellner (C)

Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet, & Stockholm Health Care Services, Region Stockholm, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH